Results 31 to 40 of about 316,749 (274)
Viabahn for femoropopliteal in-stent restenosis
Annals of Saudi Medicine, 2012 BACKGROUND AND OBJECTIVES: In-stent restenosis in the femoropopliteal artery is common (20%-40%). Treatment of in-stent restenosis is challenged by poor patency rate.
Owayed Al Shammeri +3 more
doaj +1 more source
Layer-by-layer biofabrication of coronary covered stents with clickable elastin-like recombinamers [PDF]
, 2019 Producción CientíficaCoronary artery disease is the leading cause of death around the world. Endovascular stenting is the preferred treatment option to restore blood flow in the coronary arteries due to the lower perioperative morbidity when compared ...
Fernández Colino, Alicia +7 more
core +2 more sources
Paclitaxel eluting stents versus bare metal stents restenosis
Revista Cubana de Medicina Militar, 2021 Introduction: The restenosis of the paclitaxel-eluting stents used in Cuba has not been studied. Objective: To evaluate the restenosis of paclitaxel-eluting stents and conventional stents.
Ronald Aroche Aportela +5 more
doaj
The Journal of Cardiovascular SurgeryEndovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
+7 more sources
Stent implant follow-up in intravascular optical coherence tomography images [PDF]
, 2009 The objectives of this article are (i) to utilize computer methods in detection of stent struts imaged in vivo by optical coherence tomography (OCT) during percutaneous coronary interventions (PCI); (ii) to provide measurements for the assessment ...
Carlier, Stephane Guy +4 more
core +2 more sources
Association of insulin resistance, insulin and leptin levels with coronary in-stent restenosis
The Egyptian Heart Journal, 2012 Background: In-stent restenosis remains the major limitation of coronary stent implantation. Leptin is a hormone strongly related to insulin resistance (IR).
Amira Shoukry +2 more
doaj +1 more source
Future of smart cardiovascular implants [PDF]
, 2018 Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav +2 more
core +1 more source
Revista Colombiana de Cardiología, 2012 los stents convencionales presentan tasas de restenosis intrastent entre 10% y 60%, mientras los stents liberadores de fármacos alcanzan el 10%. Para Latinoamérica, no hay reportes de restenosis intrastent en comparación con los stents convencionales y ...
Jorge A. Arroyave C., MD +1 more
doaj +1 more source
Anatomical and Technical Factors Influence the Rate of In-Stent Restenosis following Carotid Artery Stenting for the Treatment of Post-Carotid Endarterectomy Stenosis. [PDF]
PLoS ONE, 2016 Carotid artery stenting (CAS) has been advocated as an alternative to redo surgery for the treatment of post-carotid endarterectomy (CEA) stenosis. This study analyzed the efficacy of CAS for post-CEA restenosis, focusing on an analysis of technical and ...
Marine Gaudry +6 more
doaj +1 more source
Enabling Angioplasty‐Ready “Smart” Stents to Detect In‐Stent Restenosis and Occlusion
Advancement of science, 2018 Despite the multitude of stents implanted annually worldwide, the most common complication called in‐stent restenosis still poses a significant risk to patients.
Xing Chen +3 more
semanticscholar +1 more source